Role of Tau Protein in Both Physiological and Pathological Conditions

Physiological Reviews

Volumn 84, Issue 2, 2004, Pages 361-384

  Avila, Jesús ^a,b   Lucas, José J ^a   Pérez, Mar ^a   Hernández, Félix ^a  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; CELL FUNCTION; CELL STRUCTURE; HUMAN; MICROTUBULE; NERVE CELL; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; TAUOPATHY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICROTUBULES; NEURONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TAU PROTEINS; TAUOPATHIES;

EID: 1642289188     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00024.2003     Document Type: Review

References (308)

1. Abraha A, Ghoshal N, Gamblin TC, Cryns V, Berry RW, Kuret J, and Binder LI. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J Cell Sci 113: 3737-3745, 2000.
2. Al-Bassam J, Ozer RS, Safer D, Halpain S, and Milligan RA. MAP2 and tau bind longitudinally along the outer ridges of microtubule protofilaments. J Cell Biol 157: 1187-1196, 2002.
3. Aldini G, Carini M, Beretta G, Bradamante S, and Facino RM. Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction? Biochem Biophys Res Commun 298: 699-706, 2002.
4. Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, and Goedert M. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 22: 9340-9351, 2002.
5. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, and Iqbal K. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98: 6923-6928, 2001.
6. Alonso AD, Grundke-Iqbal I, Barra HS, and Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci USA 94: 298-303, 1997.
7. Alvarez G, Muñoz-Montaño JR, Satrústegui J, Avila J, Bogonez E, and Díaz-Nido J. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett 453: 260-264, 1999.
8. Anderton BH. Alzheimer's disease: clues from flies and worms. Curr Biol 9: R106-R109, 1999.
9. Andreadis A, Broderick JA, and Kosik KS. Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons. Nucleic Acids Res 23: 3585-3593, 1995.
10. Andreadis A, Brown WM, and Kosik KS. Structure and novel exons of the human tau gene. Biochemistry 31: 10626-10633, 1992.
11. Andreadis A, Wagner BK, Broderick JA, and Kosik KS. A tau promoter region without neuronal specificity. J Neurochem 66: 2257-2263, 1996.
12. Appelt DM and Balin BJ. Analysis of paired helical filaments (PHFs) found in Alzheimer's disease using freeze-drying/rotary shadowing. J Struct Biol 111: 85-95, 1993.
13. Arnold CS, Johnson GV, Cole RN, Dong DL, Lee M, and Hart GW. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J Biol Chem 271: 28741-28744, 1996.
14. Arrasate M, Pérez M, Armas-Portela R, and Avila J. Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations. FEBS Lett 446: 199-202, 1999.
15. Arrasate M, Perez M, and Avila J. Tau dephosphorylation at tau-1 site correlates with its association to cell membrane. Neurochem Res 25: 43-50, 2000.
16. Arrasate M, Pérez M, Valpuesta JM, and Avila J. Role of glycosaminoglycans in determining the helicity of paired helical filaments. Am J Pathol 151: 1115-1122, 1997.
17. Arriagada PV, Growdon JH, Hedley-Whyte ET, and Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42: 631-639, 1992.
18. Atamna H, Robinson C, Ingersoll R, Elliott H, and Ames BN. N-t-Butyl hydroxylamine is an antioxidant that reverses age-related changes in mitochondria in vivo and in vitro. FASEB J 15: 2196-2204, 2001.
19. Avila J, Lim F, Moreno F, Belmonte C, and Cuello AC. Tau function and dysfunction in neurons: its role in neurodegenerative disorders. Mol Neurobiol 25: 213-231, 2002.
20. Baas PW, Pienkowski TP, Cimbalnik KA, Toyama K, Bakalis S, Ahmad FJ, and Kosik KS. Tau confers drug stability but not cold stability to microtubules in living cells. J Cell Sci 107: 135-143, 1994.
21. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, and Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 8: 711-715, 1999.
22. Barghorn S and Mandelkow E. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 41: 14885-14896, 2002.
23. 2+/phospholipid-dependent protein kinase C. J Biol Chem 262: 17584-17590, 1987.
24. Binder LI, Frankfurter A, and Rebhun LI. The distribution of tau in the mammalian central nervous system. J Cell Biol 101: 1371-1378, 1985.
25. Brady RM, Zinkowski RP, and Binder LI. Presence of tau in isolated nuclei from human brain. Neurobiol Aging 16: 479-486, 1995.
26. Brandt R, Leger J, and Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 131: 1327-1340, 1995.
27. Bre MH and Karsenti E. Effects of brain microtubule-associated proteins on microtubule dynamics and the nucleating activity of centrosomes. Cell Motil Cytoskeleton 15: 88-98, 1990.
28. Brich J, Shie FS, Howell BW, Li R, Tus K, Wakeland EK, Jin LW, Mumby M, Churchill G, Herz J, and Cooper JA. Genetic modulation of tau phosphorylation in the mouse. J Neurosci 23: 187-192, 2003.
29. Brion JP, Tremp, G, and Octave JN. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am J Pathol 154: 255-270, 1999.
30. Brownlees J, Irving NG, Brion JP, Gibb BJM, Wagner U, Woodgett J, and Miller CCJ. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3 beta transgenes. Neuroreport 8: 3251-3255, 1997.
31. Bu B, Klunemann H, Suzuki K, Li J, Bird T, Jin LW, and Vincent I. Niemann-pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol Dis 11: 285-297, 2002.
32. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, and Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33: 95-130, 2000.
33. Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo G, Tabaton M, Morbin M, Primavera A, Carella F, Solaro C, Grisoli M, Savoiardo M, Spillantini MG, Tagliavini F, Goedert M, and Ghetti B. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 58: 667-677, 1999.
34. Caceres A and Kosik KS. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature 343: 461-463, 1990.
35. Caceres A, Potrebic S, and Kosik KS. The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons. J Neurosci 11: 1515-1523, 1991.
36. Carlier MF, Simon C, Cassoly R, and Pradel LA. Interaction between microtubule-associated protein tau and spectrin. Biochimie 66: 305-311, 1984.
37. Carmel G, Mager EM, Binder LI, and Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 271: 32789-32795, 1996.
38. Chau MF, Radeke MJ, de Ines C, Barasoain I, Kohlstaedt LA, and Feinstein SC. The microtubule-associated protein tau crosslinks to two distinct sites on each alpha and beta tubulin monomer via separate domains. Biochemistry 37: 17692-17703, 1998.
39. Chen G, Huang LD, Jiang YM, and Manji HK. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72: 1327-1330, 1999.
40. Chen J, Kanai Y, Cowan NJ, and Hirokawa N. Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons. Nature 360: 674-677, 1992.
41. Chin SS and Goldman JE. Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 55: 499-508, 1996.
42. Chirita CN, Necula M, and Kuret J. Anionic micelles and vesicles induce tau fibrillization in vitro. J Biol Chem 278: 25644-25650, 2003.
43. Cho JH and Johnson GV. Glycogen synthase kinase 3beta (GSK3 beta) phosphorylates tau at both primed and unprimed sites: differential impact on microtubule binding. J Biol Chem 278: 187-193, 2002.
44. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, DSouza I, Lee VMY, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, and Wilhelmsen KC. Pathogenic implications of mutations in the tau gene in pallidoponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA 95: 13103-13107, 1998.
45. Cleveland DW, Hwo SY, and Kirschner MW. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol 116: 227-247, 1977.
46. Cleveland DW, Hwo SY, and Kirschner MW. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 116: 207-225, 1977.
47. Collot M, Louvard D, and Singer SJ. Lysosomes are associated with microtubules and not with intermediate filaments in cultured fibroblasts. Proc Natl Acad Sci USA 81: 788-792, 1984.
48. Conrad C, Vianna C, Freeman M, and Davies P. A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease. Proc Natl Acad Sci USA 99: 7751-7756, 2002.
49. Correas I, Diaz-Nido J, and Avila J. Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain. J Biol Chem 267: 15721-15728, 1992.
50. Correas I, Padilla R, and Avila J. The tubulin-binding sequence of brain microtubule-associated proteins, tau and MAP-2, is also involved in actin binding. Biochem J 269: 61-64, 1990.
51. Couchie D, Mavilia C, Georgieff IS, Liem RK, Shelanski ML, and Nuñez J. Primary structure of high molecular weight tau present in the peripheral nervous system. Proc Natl Acad Sci USA 89: 4378-4381, 1992.
52. Craig AM and Banker G. Neuronal polarity. Annu Rev Neurosci 17: 267-310, 1994.
53. Crowther RA, Olesen OF, Jakes R, and Goedert M. The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease. FEBS Lett 309: 199-202, 1992.
54. Dantuma N and Masucci M. Stabilization signals: a novel regulatory mechanism in the ubiquitin/proteasome system. FEBS Lett 529: 22, 2002.
55. David DC, Layfield R, Serpell L, Narain Y, Goedert M, and Spillantini MG. Proteasomal degradation of tau protein. J Neurochem 83: 176-185, 2002.
56. Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, and Di Menza C. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52: 1158-1165, 1999.
57. Delisle MB, Murrell JR, Richardson R, Trofatter JA, Rascol O, Soulages X, Mohr M, Calvas P, and Ghetti B. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy. Acta Neuropathol 98: 62-77, 1999.
58. DeTure MA, Di Noto L, and Purich DL. In vitro assembly of Alzheimer-like filaments. How a small cluster of charged residues in Tau and MAP2 controls filament morphology. J Biol Chem 277: 34755-34759, 2002.
59. De Yebenes JG, Sarasa JL, Daniel SE, and Lees AJ. Familial progressive supranuclear palsy. Description of a pedigree and review of the literature. Brain 118: 1095-1103, 1995.
60. Di Maria E, Tabaton M, Vigo T, Abbruzzese G, Bellone E, Donati C, Frasson E, Marchese R, Montagna P, Munoz DG, Pramstaller PP, Zanusso G, Ajmar F, and Mandich P. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 47: 374-377, 2000.
61. DiTella MC, Feiguin F, Carri N, Kosik KS, and Caceres A. MAP-1B/TAU functional redundancy during laminin-enhanced axonal growth. J Cell Sci 109: 467-477, 1996.
62. Dotti CG, Banker GA, and Binder LI. The expression and distribution of the microtubule-associated proteins tau and microtubule-associated protein 2 in hippocampal neurons in the rat in situ and in cell culture. Neuroscience 23: 121-130, 1987.
63. Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, Takashima A, Gouras GK, Greengard P, and Xu H. Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci USA 100: 721-726, 2003.
64. Drechsel DN, Hyman AA, Cobb MH, and Kirschner MW. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 3: 1141-1154, 1992.
65. Drewes G, Lichtenberg KB, Doring F, Mandelkow EM, Biernat J, Goris J, Doree M, and Mandelkow E. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J 11: 2131-2138, 1992.
66. Drubin DG and Kirschner MW. Tau protein function in living cells. J Cell Biol 103: 2739-2746, 1986.
67. D'Souza I and Schellenberg GD. Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion. J Biol Chem 275: 17700-17709, 2000.
68. D'Souza I and Schellenberg GD. tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5′ and 3′ splice sites. J Biol Chem 277: 26587-26599, 2002.
69. Dudek SM and Johnson GV. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau. J Neurochem 61: 1159-1162, 1993.
70. Duff K, Knight H, Refolo LM, Sanders S, Yu X, Picciano M, Malester B, Hutton M, Adamson J, Goedert M, Burki K, and Davies P. Characterization of pathology in transgenic mice overexpressing human genomic and cDNA tau transgenes. Neurobiol Dis 7: 87-98, 2000.
71. Eble AS, Thorpe SR, and Baynes JW. Nonenzymatic glucosylation and glucose-dependent cross-linking of protein. J Biol Chem 258: 9406-9412, 1983.
72. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow EM, and Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol 143: 777-794, 1998.
73. Fath T, Eidenmuller J, and Brandt R. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci 22: 9733-9741, 2002.
74. Fellous A, Francon J, Lennon AM, and Nunez J. Microtubule assembly in vitro. Purification of assembly-promoting factors. Eur J Biochem 78: 167-174, 1977.
75. Frame S, Cohen P, and Biondi RM. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7: 1321-1327, 2001.
76. García de Ancos J, Correas I, and Avila J. Differences in microtubule binding and self-association abilities of bovine brain tau isoforms. J Biol Chem 268: 7976-7982, 1993.
77. Geddes JF, Hughes AJ, Lees AJ, and Daniel SE. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex. Brain 116: 281-302, 1993.
78. Ghoshal N, Garcia-Sierra F, Wuu J, Leurgans S, Bennett DA, Berry RW, and Binder LI. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol 177: 475-493, 2002.
79. Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, and Lee VM. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300: 636-640, 2003.
80. Giunta S and Galeazzi G. Cytochrome c-induces protein-tau aggregates due to the dityrosine crosslinkings (Abstract). Neurobiol Aging 23: S515, 2002.
81. G-Lee SLK, Newman ST, Lu M, and Liu Y. A new molecular interactor for tau protein. Soc Neurosci Abstr 22: 975, 1996.
82. Goedert M. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Philos Trans R Soc Lond B Biol Sci 354: 1101-1118, 1999.
83. Goedert M, Baur CP, Ahringer J, Jakes R, Hasegawa M, Spillantini MG, Smith MJ, and Hill F. PTL-1, a microtubule-associated protein with tau-like repeats from the nematode Caenorhabditis elegans. J Cell Sci 109: 2661-2672, 1996.
84. Goedert M, Cohen ES, Jakes R, and Cohen P. p42 map kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease. FEBS Lett 312: 95-99, 1992.
85. Goedert M, Crowther RA, and Spillantini MG. Tau mutations cause frontotemporal dementias. Neuron 21: 955-958, 1998.
86. Goedert M, Hasegawa M, Jakes R, Lawler S, Cuenda A, and Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett 409: 57-62, 1997.
87. Goedert M, Jakes R, Qi Z, Wang JH, and Cohen P. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J Neurochem 65: 2804-2807, 1995.
88. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, and Crowther RA. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383: 550-553, 1996.
89. Goedert M, Satumtira S, Jakes R, Smith MJ, Kamibayashi C, White CL III, and Sontag E. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations. J Neurochem 75: 2155-2162, 2000.
90. Goedert M and Spillantini MG. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. Biochim Biophys Acta 1502: 110-121, 2000.
91. Goedert M, Spillantini MG, Cairns NJ, and Crowther RA. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8: 159-168, 1992.
92. Goedert M, Spillantini MG, and Crowther RA. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc Natl Acad Sci USA 89: 1983-1987, 1992.
93. Goedert M, Spillantini MG, Jakes R, Rutherford D, and Crowther RA. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3: 519-526, 1989.
94. Goedert M, Spillantini MG, Potier MC, Ulrich J, and Crowther RA. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8: 393-399, 1989.
95. Gomez-Ramos A, Diaz-Nido J, Smith MA, Perry G, and Avila J. Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells. J Neurosci Res 71: 863-870, 2003.
96. Gong CX, Grundke-Iqbal I, Damuni Z, and Iqbal K. Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease. FEBS Lett 341: 94-98, 1994.
97. Gong CX, Grundke-Iqbal I, and Iqbal K. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 61: 765-772, 1994.
98. Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, and Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 275: 5535-5544, 2000.
99. Gong CX, Singh TJ, Grundke-Iqbal I, and Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61: 921-927, 1993.
100. Gong CX, Singh TJ, Grundke-Iqbal I, and Iqbal K. Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin). J Neurochem 62: 803-806, 1994.
101. Gonzalez-Billault C, Engelke M, Jimenez-Mateos EM, Wandosell F, Caceres A, and Avila J. Participation of structural microtubule-associated proteins (MAPs) in the development of neuronal polarity. J Neurosci Res 67: 713-719, 2002.
102. Goode BL, Chau M, Denis PE, and Feinstein SC. Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenerative disease. J Biol Chem 275: 38182-38189, 2000.
103. Goode BL, Denis PE, Panda D, Radeke MJ, Miller HP, Wilson L, and Feinstein SC. Functional interactions between the prolinerich and repeat regions of tau enhance microtubule binding and assembly. Mol Biol Cell 8: 353-365, 1997.
104. Gordon-Krajcer W, Yang L, and Ksiezak-Reding H. Conformation of paired helical filaments blocks dephosphorylation of epitopes shared with fetal tau except Ser199/202 and Ser202/Thr205. Brain Res 856: 163-175, 2000.
105. Gotz J, Probst A, Spillantini MG, Schafer T, Jakes R, Burki K, and Goedert M. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 14: 1304-1313, 1995.
106. Gotz J, Tolnay M, Barmettler R, Ferrari A, Burki K, Goedert M, Probst A, and Nitsch RM. Human tau transgenic mice. Towards an animal model for neuro- and glialfibrillary lesion formation. Adv Exp Med Biol 487: 71-83, 2001.
107. Goux WJ. The conformations of filamentous and soluble tau associated with Alzheimer paired helical filaments. Biochemistry 41: 13798-13806, 2002.
108. Greenberg SG, Davies P, Schein JD, and Binder LI. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267: 564-569, 1992.
109. Greenwood JA and Johnson GV. Localization and in situ phosphorylation state of nuclear tau. Exp Cell Res 220: 332-337, 1995.
110. Griffith LM and Pollard TD. The interaction of actin filaments with microtubules and microtubule-associated proteins. J Biol Chem 257: 9143-9151, 1982.
111. Grover A, Houlden H, Baker M, Adamson J, Lewis J, Prihar G, Pickering-Brown S, Duff K, and Hutton M. 5′ Splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem 274: 15134-15143, 1999.
112. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, and Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83: 4913-4917, 1986.
113. Hall GF, Chu B, Lee G, and Yao J. Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease. J Cell Sci 113: 1373-1387, 2000.
114. Hall GF, Lee VM, Lee G, and Yao J. Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy. Am J Pathol 158: 235-246, 2001.
115. Hall GF, Yao J, and Lee G. Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ. Proc Natl Acad Sci USA 94: 4733-4738, 1997.
116. Hanger DP, Gibb GM, de Silva R, Boutajangout A, Brion JP, Revesz T, Lees AJ, and Anderton BH. The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies. FEBS Lett 531: 538-542, 2002.
117. Hanger DP, Hughes K, Woodgett JR, Brion JP, and Anderton BH. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147: 58-62, 1992.
118. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, and Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369: 488-491, 1994.
119. Hartmann AM, Rujescu D, Giannakouros T, Nikolakaki E, Goedert M, Mandelkow EM, Gao QS, Andreadis A, and Stamm S. Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors. Mol Cell Neurosci 18: 80-90, 2001.
120. Hartzler AW, Zhu X, Siedlak SL, Castellani RJ, Avila J, Perry G, and Smith MA. The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau. Neurobiol Aging 23: 855, 2002.
121. Hasegawa M, Jakes R, Crowther RA, Lee VMY, Ihara Y, and Goedert M. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tan protein. FEBS Lett 384: 25-30, 1996.
122. Hashiguchi M, Saito T, Hisanaga S, and Hashiguchi T. Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau. J Biol Chem 277: 44525-44530, 2002.
123. Hashiguchi M, Sobue K, and Paudel HK. 14-3-3Zeta is an effector of tau protein phosphorylation. J Biol Chem 275: 25247-25254, 2000.
124. Hashimoto M, Sagara Y, Langford D, Everall IP, Mallory M, Everson A, Digicaylioglu M, and Masliah E. Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection. J Biol Chem 277: 32985-32991, 2002.
125. Heidary G and Fortini ME. Identification and characterization of the Drosophila tau homolog. Mech Dev 108: 171-178, 2001.
126. Hernandez F, Borrell J, Guaza C, Avila J, and Lucas JJ. Spatial learning deficit in transgenic mice that conditionally overexpress GSK-3beta in the brain but do not form tau filaments. J Neurochem 83: 1529-1533, 2002.
127. Hernandez F, Lucas JJ, Cuadros R, and Avila J. GSK-3 dependent phosphoepitopes recognized by PHF-1 and AT-8 antibodies are present in different tau isoforms. Neurobiol Aging. In press.
128. Hernandez F, Perez M, Lucas JJ, and Avila J. Are intracellular paired helical filaments (PHFs) from Alzheimer's disease toxic for a neuron? Brain Aging 1: 12-15, 2001.
129. Hershko A and Ciechanover A. The ubiquitin system. Annu Rev Biochem 67: 425-479, 1998.
130. Hetman M, Cavanaugh JE, Kimelman D, and Xia Z. Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci 20: 2567-2574, 2000.
131. Heutink P. Untangling tau-related dementia. Hum Mol Genet 9: 979-986, 2000.
132. Himmler A. Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family. Mol Cell Biol 9: 1389-1396, 1989.
133. Himmler A, Drechsel D, Kirschner MW, and Martin DJ. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol Cell Biol 9: 1381-1388, 1989.
134. Hirokawa N, Shiomura Y, and Okabe S. Tau proteins: the molecular structure and mode of binding on microtubules. J Cell Biol 107: 1449-1459, 1988.
135. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, and Woodgett JR. Requirement for glycogen synthase kinase-3 beta in cell survival and NF-kappaB activation. Nature 406: 86-90, 2000.
136. Hoenicka J, Arrasate M, de Yebenes JG, and Avila J. A two-hybrid screening of human Tau protein: interactions with Alu-derived domain. Neuroreport 13: 343-349, 2002.
137. Hoenicka J, Perez M, PerezTur J, Barabash A, Godoy M, Vidal L, Astarloa R, Avila J, Nygaard T, and deYebenes JG. The tau gene A0 allele and progressive supranuclear palsy. Neurology 53: 1219-1225, 1999.
138. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A, Morris JC, Wilhelmsen KC, Schellenberg GD, Trojanowski JQ, and Lee VM. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282: 1914-1917, 1998.
139. Hoshi M, Sato M, Matsumoto S, Noguchi A, Yasutake K, Yoshida N, and Sato K. Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β. Proc Natl Acad Sci USA 100: 6370-6375, 2003.
140. Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, and Hutton M. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56: 1702-1706, 2001.
141. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Heutink P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basul H, Lannfelt L, Neystar M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JBJ, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Timothy L, and Heutink P. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705, 1998.
142. Hwang SC, Jhon DY, Bae YS, Kim JH, and Rhee SG. Activation of phospholipase C-gamma by the concerted action of tau proteins and arachidonic acid. J Biol Chem 271: 18342-18349, 1996.
143. Hyman BT and Gomez-Isla T. Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging 15: 353-354, 379-380, 1994.
144. Ihara Y, Nukina N, Miura R, and Ogawara M. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J Biochem 99: 1807-1810, 1986.
145. Ikegami S, Harada A, and Hirokawa N. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice. Neurosci Lett 279: 129-132, 2000.
146. Imahori K and Uchida T. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J Biochem 121: 179-188, 1997.
147. Ingram EM and Spillantini MG. Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol Med 8: 555-562, 2002.
148. Iqbal K, Alonso AD, Gong CX, Khatoon S, Pei JJ, Wang JZ, and Grundke-Iqbal I. Tau phosphatases. In: Brain Microtubule Associated, edited by Avila J, Brandt R, and Kosik KS. Chur, Switzerland: Harwood Academic, 1997, p. 95-111.
149. Iqbal K, Zaidi T, Bancher C, and Grundke-Iqbal I. Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation. FEBS Lett 349: 104-108, 1994.
150. Irminger-Finger I, Laymon RA, and Goldstein LS. Analysis of the primary sequence and microtubule-binding region of the Drosophila 205K MAP. J Cell Biol 111: 2563-2572, 1990.
151. Ishiguro K. Tau protein kinases. In: Brain Microtubule Associated, edited by Avila J, Brandt R, and Kosik KS. Chur, Switzerland: Harwood Academic, 1997, p. 73-93.
152. Ishiguro K, Shiratsuchi A, Sato S, Omori A, Arioka M, Kobayashi S, Uchida T, and Imahori K. Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 325: 167-172, 1993.
153. Ishiguro K, Takamatsu M, Tomizawa K, Omori A, Takahashi M, Arioka M, Uchida T, and Imahori K. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J Biol Chem 267: 10897-10901, 1992.
154. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, and Lee VM. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24: 751-762, 1999.
155. Ishihara T, Zhang B, Higuchi M, Yoshiyama Y, Trojanowski JQ, and Lee VM. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol 158: 555-562, 2001.
156. Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, and Geschwind DH. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34: 509-519, 2002.
157. Jenkins SM and Johnson GVW. Tau complexes with phospholipase C-gamma in situ. Neuroreport 9: 67-71, 1998.
158. Jensen PH, Hager H, Nielsen MS, Hojrup P, Gliemann J, and Jakes R. Alpha-synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J Biol Chem 274: 25481-25489, 1999.
159. Jicha GA, Rockwood JM, Berenfeld B, Hutton M, and Davies P. Altered conformation of recombinant frontotemporal dementia-17 mutant tau proteins. Neurosci Lett 260: 153-156, 1999.
160. Johnson GV and Bailey CD. Tau, where are we now? J Alzheimer's Dis 4: 375-398, 2002.
161. Johnson GV, Jope RS, and Binder LI. Proteolysis of tau by calpain. Biochem Biophys Res Commun 163: 1505-1511, 1989.
162. Kanai Y, Chen J, and Hirokawa N. Microtubule bundling by tau proteins in vivo: analysis of functional domains. EMBO J 11: 3953-3961, 1992.
163. Kar S, Fan J, Smith MJ, Goedert M, and Amos LA. Repeat motifs of tau bind to the insides of microtubules in the absence of taxol. EMBO J 22: 70-77, 2003.
164. Kerokoski P, Suuronen T, Salminen A, Soininen H, and Pirttila T. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation. Biochem Biophys Res Commun 298: 693-698, 2002.
165. Khatoon S, Grundke-Iqbal I, and Iqbal K. Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem 59: 750-753, 1992.
166. Khatoon S, Grundke-Iqbal I, and Iqbal K. Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 351: 80-84, 1994.
167. Kidd M. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197: 192-193, 1963.
168. Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, and Trotter J. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J Neurosci 22: 698-707, 2002.
169. Knops J, Kosik KS, Lee G, Pardee JD, Cohen-Gould L, and McConlogue L. Overexpression of tau in a nonneuronal cell induces long cellular processes. J Cell Biol 114: 725-733, 1991.
170. Knowles R, LeClerc N, and Kosik KS. Organization of actin and microtubules during process formation in tau-expressing Sf9 cells. Cell Motil Cytoskeleton 28: 256-264, 1994.
171. Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, and Grundke-Iqbal I. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268: 24374-24384, 1993.
172. Kosik KS, Tau: structure and function. In: Brain Microtubule Associated, edited by Avila J, Brandt R, and Kosik KS. Chur, Switzerland: Harwood Academic, 1997, p. 43-52.
173. Kosik KS, Orecchio LD, Bakalis S, and Neve RL. Developmentally regulated expression of specific tau sequences. Neuron 2: 1389-1397, 1989.
174. Ledesma MD, Bonay P, and Avila J. Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J Neurochem 65: 1658-1664, 1995.
175. Ledesma MD, Bonay P, Colaço C, and Avila J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 269: 21614-21619, 1994.
176. Ledl FaS E. New aspects of the Maillard reaction in foods and in the human body. Angew Chem 29: 565-706, 1990.
177. Lee G, Cowan N, and Kirschner M. The primary structure and heterogeneity of tau protein from mouse brain. Science 239: 285-288, 1988.
178. Lee G, Newman ST, Gard DL, Band H, and Panchamoorthy G. Tau interacts with src-family non-receptor tyrosine kinases. J Cell Sci 111: 3167-3177, 1998.
179. Lee G and Rook SL. Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. J Cell Sci 102: 227-237, 1992.
180. Lee SC, Kuan CY, Wen ZD, and Yang SD. The naturally occurring PKC inhibitor sphingosine and tumor promoter phorbol ester potentially induce tyrosine phosphorylation/activation of oncogenic proline-directed protein kinase F-A/GSK-3 alpha in a common signalling pathway. J Protein Chem 17: 15-27, 1998.
181. Lee VM, Balin BJ, Otvos L Jr, and Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251: 675-678, 1991.
182. Lee VM, Goedert M, and Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 24: 1121-1159, 2001.
183. Lefebvre T, Ferreira S, Dupont-Wallois L, Bussiere T, Dupire MJ, Delacourte A, Michalski JC, and Caillet-Boudin ML. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins: a role in nuclear localization. Biochim Biophys Acta 1619: 167-176, 2003.
184. Lesort M, Attanavanich K, Zhang JW, and Johnson GVW. Distinct nuclear localization and activity of tissue transglutaminase. J Biol Chem 273: 11991-11994, 1998.
185. Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, Dickson DW, Davies P, and Hutton M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genet 25: 402-405, 2000.
186. Li M, Wang X, Meintzer MK, Laessig T, Birnbaum MJ, and Heidenreich KA. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol Cell Biol 20: 9356-9363, 2000.
187. Li YJ and Low WC. Intra-retrosplenial cortical grafts of cholinergic neurons: functional incorporation and restoration of high affinity choline uptake. Neurochem Res 22: 589-595, 1997.
188. Liang LGII and Iqbal K. Memantine restores the okadaic acid induced hyperphosphorylation, presumably by acting on protein phosphatase 2A activities, like that of PP2A (Abstract). Neurobiol Aging 23: S111, 2002.
189. Liao H, Li YR, Brautigan DL, and Gundersen GG. Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein Tau. J Biol Chem 273: 21901-21908, 1998.
190. Lim F, Hernandez F, Lucas JJ, Gomez-Ramos P, Moran MA, and Avila J. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Mol Cell Neurosci 18: 702-714, 2001.
191. Lippa CF, Zhukareva V, Kawarai T, Uryu K, Shafiq M, Nee LE, Grafman J, Liang Y, St George-Hyslop PH, Trojanowski JQ, and Lee VM. Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation. Ann Neurol 48: 850-858, 2000.
192. Liu F, Iqbal K, Grundke-Iqbal I, and Gong CX. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. FEBS Lett 530: 209-214, 2002.
193. Liu F, Zaidi T, Iqbal K, Grundke-Iqbal I, and Gong CX. Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5. Neuroscience 115: 829-837, 2002.
194. Liu F, Zaidi T, Iqbal K, Grundke-Iqbal I, Merkle RK, and Gong CX. Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease. FEBS Lett 512: 101-106, 2002.
195. Loomis PA, Howard TH, Castleberry RP, and Binder LI. Identification of nuclear tau isoforms in human neuroblastoma cells. Proc Natl Acad Sci USA 87: 8422-8426, 1990.
196. Lovestone S and Reynolds CH. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78: 309-324, 1997.
197. Lu M and Kosik KS. Competition for microtubule-binding with dual expression of tau missense and splice isoforms. Mol Biol Cell 12: 171-184, 2001.
198. Lu PJ, Wulf G, Zhou XZ, Davies P, and Lu KP. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399: 784-788, 1999.
199. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, and Avila J. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20: 27-39, 2001.
200. Maccioni RB, Vera JC, Dominguez J, and Avila J. A discrete repeated sequence defines a tubulin binding domain on microtubule-associated protein tau. Arch Biochem Biophys 275: 568-579, 1989.
201. Maillard LC. Action des acides aminés sur les sucres; formation des melanoidines par voie méthodique. CR Hebd Séances Acad Sci 154: 66-68, 1912.
202. Mailliot C, Trojanowski JQ, and Lee VM. Impaired tau protein function following nitration-induced oxidative stress in vitro and in vivo (Abstract). Neurobiol Aging 23: S415, 2002.
203. Mandell JW and Banker GA. A spatial gradient of tau protein phosphorylation in nascent axons. J Neurosci 16: 5727-5740, 1996.
204. Mattson MP. Neuronal death and GSK-3beta: a tau fetish? Trends Neurosci 24: 255-256, 2001.
205. Matus A. Microtubule-associated proteins: their potential role in determining neuronal morphology. Annu Rev Neurosci 11: 29-44, 1988.
206. Mayer A, Siegel NR, Schwartz AL, and Ciechanover A. Degradation of proteins with acetylated amino termini by the ubiquitin system. Science 244: 1480-1483, 1989.
207. Miller ML and Johnson GVW. Transglutaminase cross-linking of the tau protein. J Neurochem 65: 1760-1770, 1995.
208. Minoura K, Tomoo K, Ishida T, Hasegawa H, Sasaki M, and Taniguchi T. Amphipathic helical behavior of the third repeat fragment in the tau microtubule-binding domain, studied by (1)H NMR spectroscopy. Biochem Biophys Res Commun 294: 210-214, 2002.
209. Mitchison T and Kirschner M. Cytoskeletal dynamics and nerve growth. Neuron 1: 761-772, 1988.
210. Montejo de Garcini E and Avila J. In vitro conditions for the self-polymerization of the microtubule-associated protein, tau factor. J Biochem 102: 1415-1421, 1987.
211. Montejo de Garcini E, Carrascosa JL, Gorreas I, Nieto A, and Avila J. Tau factor polymers are similar to paired helical filaments of Alzheimer's disease. FEBS Lett 236: 150-154, 1988.
212. Montejo de Garcini E, Diez JC, and Avila J. Quantitation and characterization of tau factor in porcine tissues. Biochim Biophys Acta 881: 456-461, 1986.
213. Montejo de Garcini E, Serrano L, and Avila J. Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease. Biochem Biophys Res Commun 141: 790-796, 1986.
214. Moreno-Herrero F, Valpuesta JM, Perez M, Colchero J, Baro AM, Avila J, and Montejo De Garcini E. Characterization by atomic force microscopy and cryoelectron microscopy of tau polymers assembled in Alzheimer's disease. J Alzheimers Dis 3: 443-451, 2001.
215. Mori H, Kondo J, and Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235: 1641-1644, 1987.
216. Morishima KM, Hasegawa M, Takio K, Suzuki M, Titani K, and Ihara Y. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10: 1151-1160, 1993.
217. Morsch R, Simon W, and Coleman PD. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58: 188-197, 1999.
218. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. Am J Pathol 143: 565-578, 1993.
219. Murphey RK and Godenschwege TA. New roles for ubiquitin in the assembly and function of neuronal circuits. Neuron 36: 5-8, 2002.
220. Murrell JR, Spillantini MG, Zolo P, Guazzelli M, Smith MJ, Hasegawa M, Redi F, Crowther RA, Pietrini P, Ghetti B, and Goedert M. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. J Neuropathol Exp Neurol 58: 1207-1226, 1999.
221. Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, Yamazaki H, and Hirokawa N. KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79: 1209-1220, 1994.
222. Nelson PT, Stefansson K, Gulcher J, and Saper CB. Molecular evolution of tau protein: implications for Alzheimer's disease. J Neurochem 67: 1622-1632, 1996.
223. Neve RL, Harris P, Kosik KS, Kurnit DM, and Donlon TA. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res 387: 271-280, 1986.
224. Norlund MA, Lee JM, Zainelli GM, and Muma NA. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease. Brain Res 851: 154-163, 1999.
225. Nuñez J. Immature and mature variants of MAP2 and tau proteins and neuronal plasticity. Trends Neurosci 11: 477-479, 1988.
226. Ohkubo N, Lee YD, Morishima A, Terashima T, Kikkawa S, Tohyama M, Sakanaka M, Tanaka J, Maeda N, Vitek MP, and Mitsuda N. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/diables-1/ glycogen synthase kinase-3beta cascade. FASEB J 17: 295-297, 2003.
227. Panda D, Goode BL, Feinstein SC, and Wilson L. Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau. Biochemistry 34: 11117-11127, 1995.
228. Pap M and Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 273: 19929-19932, 1998.
229. Pastor P, Ezquerra M, Tolosa E, Munoz E, Marti MJ, Valldeoriola F, Molinuevo JL, Calopa M, and Oliva R. Further extension of the H1 haplotype associated with progressive supranuclear palsy. Mov Disord 17: 550-556, 2002.
230. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, and Tsai LH. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402: 615-622, 1999.
231. Perez M, Arrasate M, Montejo De Garcini E, Munoz V, and Avila J. In vitro assembly of tau protein: mapping the regions involved in filament formation. Biochemistry 40: 5983-5991, 2001.
232. Perez M, Cuadros R, Smith MA, Perry G, and Avila J. Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal. FEBS Lett 486: 270-274, 2000.
233. Perez M, Hernandez F, Gomez-Ramos A, Smith M, Perry G, and Avila J. Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur J Biochem 269: 1484-1489, 2002.
234. Perez M, Lim F, Arrasate M, and Avila J. The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules. J Neurochem 74: 2583-2589, 2000.
235. Perez M, Valpuesta JM, Medina M, Montejo de Garcini E, and Avila J. Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J Neurochem 67: 1183-1190, 1996.
236. Pollanen MS, Markiewicz P, Bergeron C, and Goh MC. Twisted ribbon structure of paired helical filaments revealed by atomic force microscopy. Am J Pathol 144: 869-873, 1994.
237. Poorkaj P, Muma NA, Zhukareva V, Cochran EJ, Shannon KM, Hurtig H, Koller WC, Bird TD, Trojanowski JQ, Lee VM, and Schellenberg GD. An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann Neurol 52: 511-516, 2002.
238. Probst A, Gotz J, Wiederhold KH, Tolnay M, Mistl C, Jaton AL, Hong M, Ishihara T, Lee VM, Trojanowski JQ, Jakes R, Crowther RA, Spillantini MG, Burki K, and Goedert M. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol 99: 469-481, 2000.
239. Rapoport M, Dawson HN, Binder LI, Vitek MP, and Ferreira A. Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci USA 99: 6364-6369, 2002.
240. Reynolds H, Williamson R, Anderton B. Tau binds to phosphatidylinositol-3-kinase, GRB2, phospholipase C gamma-1 and SRC-family kinases through SH3 domain (Abstract). Neurobiol Aging 23: S266, 2002.
241. Rizzini C, Goedert M, Hodges JR, Smith MJ, Jakes R, Hills R, Xuereb JH, Crowther RA, and Spillantini MG. Tau gene mutation K257T causes a tauopathy similar to Pick's disease. J Neuropathol Exp Neurol 59: 990-1001, 2000.
242. Rizzu P, Van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A, Niermeijer MF, Hillebrand M, Ravid R, Oostra BA, Goedert M, van Duijn CM, and Heutink P. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 64: 414-421, 1999.
243. Rohn T and Davis M. Caspase cleavage of tau in the Alzheimer's disease brain (Abstract). Neurobiol Aging 23: S519, 2002.
244. Ruben GC, Iqbal K, Grundke II, and Johnson JJ. The organization of the microtubule associated protein tau in Alzheimer paired helical filaments. Brain Res 602: 1-13, 1993.
245. Ruben GC, Iqbal K, Grundke-Iqbal I, Wisniewski HM, Ciardelli TL, and Johnson JE Jr. The microtubule-associated protein tau forms a triple-stranded left-hand helical polymer. J Biol Chem 266: 22019-22027, 1991.
246. Sadot E, Gurwitz D, Barg J, Behar L, Ginzburg I, and Fisher A. Activation of m(1) muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells. J Neurochem 66: 877-880, 1996.
247. Sadot E, Heicklenklein A, Barg J, Lazarovici P, and Ginzburg I. Identification of a tau promoter region mediating tissue-specific-regulated expression in PC12 cells. J Mol Biol 256: 805-812, 1996.
248. Sadqi M, Hernandez F, Pan U, Perez M, Schaeberle MD, Avila J, and Munoz V. Alpha-helix structure in Alzheimer's disease aggregates of tau-protein. Biochemistry 41: 7150-7155, 2002.
249. Sahara N, Lewis J, DeTure M, McGowan E, Dickson DW, Hutton M, and Yen SH. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility. J Neurochem 83: 1498-1508, 2002.
250. Schweers O, Mandelkow EM, Biernat J, and Mandelkow E. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sci USA 92: 8463-8467, 1995.
251. Scott CW, Spreen RC, Herman JL, Chow FP, Davison MD, Young J, and Caputo CB. Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly. J Biol Chem 268: 1166-1173, 1993.
252. Sergeant N, Bussiere T, Vermersch P, Lejeune JP, and Delacourte A. Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins. Neuroreport 6: 2217-2220, 1995.
253. Serrano L, Montejo de Garcini E, Hernandez MA, and Avila J. Localization of the tubulin binding site for tau protein. Eur J Biochem 153: 595-600, 1985.
254. Shahani N and Brandt R. Functions and malfunctions of the tau proteins. Cell Mol Life Sci 59: 1668-1680, 2002.
255. Shelanski ML, Gaskin F, and Cantor CR. Microtubule assembly in the absence of added nucleotides. Proc Natl Acad Sci USA 70: 765-768, 1973.
256. Singh TJ, Grundke-Iqbal I, and Iqbal K. Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state. J Neurochem 64: 1420-1423, 1995.
257. Singh TJ, Zaidi T, Grundkeiqbal I, and Iqbal K. Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases. FEBS Lett 358: 4-8, 1995.
258. Smith MA, Sayre LM, Monnier VM, and Perry G. Radical AGE-ing in Alzheimer's disease. Trends Neurosci 18: 172-176, 1995.
259. Sobue K, Agarwal-Mawal A, Li W, Sun W, Miura Y, and Paudel HK. Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. J Biol Chem 275: 16673-16680, 2000.
260. Sontag E, NunbhakdiCraig V, Lee G, Brandt R, Kamibayashi C, Kuret J, White CL, Mumby MC, and Bloom GS. Molecular interactions among protein phosphatase 2A, tau, and microtubules: implications for the regulation of tau phosphorylation and the development of tauopathies. J Biol Chem 274: 25490-25498, 1999.
261. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, and Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 95: 7737-7741, 1998.
262. Spittaels K, van den Haute C, Geerts H, Moechars D, and van Leuven F. Expression of human GSK3B (S9A) reduces brain size in transgenic mice. Proc Int Conf Alzheimer's Disease Related Disorders 6th Amsterdam The Netherlands 1998.
263. Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I, Geerts H, Mercken M, Sciot R, Van Lommel A, Loos R, and Van Leuven F. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 155: 2153-2165, 1999.
264. Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, Bruynseels K, Lasrado R, Vandezande K, Laenen I, Boon T, Van Lint J, Vandenheede J, Moechars D, Loos R, and Van Leuven F. Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem 275: 41340-41349, 2000.
265. Strack S, Ruediger R, Walter G, Dagda RK, Barwacz CA, and Cribbs JT. Protein phosphatase 2A holoenzyme assembly: identification of contacts between B-family regulatory and scaffolding A subunits. J Biol Chem 277: 20750-20755, 2002.
266. Szucs K, Ledesma MD, Dombradi V, Gergely P, Avila J, and Friedrich P. Dephosphorylation of tau protein from Alzheimer's disease patients. Neurosci Lett 165: 175-178, 1994.
267. Takashima A, Murayama M, Murayama O, Kohno T, Honda T, Yasutake K, Nihonmatsu N, Mercken M, Yamaguchi H, Sugihara S, and Wolozin B. Presenilin 1 associates with glycogen synthase kinase-3 beta and its substrate tau. Proc Natl Acad Sci USA 95: 9637-9641, 1998.
268. Takei Y, Teng J, Harada A, and Hirokawa N. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J Cell Biol 150: 989-1000, 2000.
269. Tanaka Y, Kanai Y, Okada Y, Nonaka S, Takeda S, Harada A, and Hirokawa N. Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria. Cell 93: 1147-1158, 1998.
270. Tanemura K, Murayama M, Akagi T, Hashikawa T, Tominaga T, Ichikawa M, Yamaguchi H, and Takashima A. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 22: 133-141, 2002.
271. Taniguchi S, Fujita Y, Hayashi S, Kakita A, Takahashi H, Murayama S, Saido TC, Hisanaga S, Iwatsubo T, and Hasegawa M. Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett 489: 46-50, 2001.
272. Tatebayashi Y, Iqbal K, and Grundke-Iqbal I. Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus. J Neurosci 19: 5245-5254, 1999.
273. Tatebayashi Y, Miyasaka T, Chui DH, Akagi T, Mishima K, Iwasaki K, Fujiwara M, Tanemura K, Murayama M, Ishiguro K, Planel E, Sato S, Hashikawa T, and Takashima A. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc Natl Acad Sci USA 99: 13896-13901, 2002.
274. Terwel D, Dewachter L, and Van Leuven F. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Neuromol Med 2: 151-165, 2002.
275. Trinczek B, Biernat J, Baumann K, Mandelkow EM, and Mandelkow E. Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules. Mol Biol Cell 6: 1887-1902, 1995.
276. Troncoso JC, Costello A, Watson AL Jr, and Johnson GV. In vitro polymerization of oxidized tau into filaments. Brain Res 613: 313-316, 1993.
277. Truong AB, Masters SC, Yang H, and Fu H. Role of the 14-3-3 C-terminal loop in ligand interaction. Proteins 49: 321-325, 2002.
278. Tseng HC, Lu Q, Henderson E, and Graves DJ. Phosphorylated tau can promote tubulin assembly. Proc Natl Acad Sci USA 96: 9503-9508, 1999.
279. Vafai SB and Stock JB. Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease. FEBS Lett 518: 1-4, 2002.
280. Vanier MT, Duthel S, Rodriguez-Lafrasse C, Pentchev P, and Carstea ED. Genetic heterogeneity in Niemann-Pick C disease: a study using somatic cell hybridization and linkage analysis. Am J Hum Genet 58: 118-125, 1996.
281. Vanier MT, Rodriguez-Lafrasse C, Rousson R, Gazzah N, Juge MC, Pentchev PG, Revol A, and Louisot P. Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. Biochim Biophys Acta 1096: 328-337, 1991.
282. Varani L, Hasegawa M, Spillantini MG, Smith MJ, Murrell JR, Ghetti B, Klug A, Goedert M, and Varani G. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci USA 96: 8229-8234, 1999.
283. Verpillat P, Ricard S, Hannequin D, Dubois B, Bou J, Camuzat A, Pradier L, Frebourg T, Brice A, Clerget-Darpoux F, Deleuze JF, and Campion D. Is the Saitohin gene involved in neurodegenerative diseases? Ann Neurol 52: 829-832, 2002.
284. Von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, and Mandelkow E. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif [(306)VQIVYK(311)] forming beta structure. Proc Natl Acad Sci USA 97: 5129-5134, 2000.
285. Wandosell F and Avila J. Microtubule-associated proteins present in different developmental stages of Drosophila melanogaster. J Cell Biochem 35: 83-92, 1987.
286. Wang JZ, Gong CX, Zaidi T, Grundke-Iqbal I, and Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem 270: 4854-4860, 1995.
287. Wang JZ, Grundkeiqbal I, and Iqbal K. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease. Nature Med 2: 871-875, 1996.
288. Watanabe A, Takio K, and Ihara Y. Deamidation and isoaspartate formation in smeared tan in paired helical filaments: unusual properties of the microtubule-binding domain of tau. J Biol Chem 274: 7368-7378, 1999.
289. Watanabe T, Ihara N, Itoh T, Fujita T, and Sugimoto Y. Deletion mutation in Drosophila ma-l homologous, putative molybdopterin cofactor sulfurase gene is associated with bovine xanthinuria type II. J Biol Chem 275: 21789-21792, 2000.
290. Wedemeyer WJ, Welker E, and Scheraga HA. Proline cis-trans isomerization and protein folding. Biochemistry 41: 14637-14644, 2002.
291. Weingarten MD, Lockwood AH, Hwo SY, and Kirschner MW. A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72: 1858-1862, 1975.
292. Wilhelmsen KC. The tangled biology of tau. Proc Natl Acad Sci USA 96: 7120-7121, 1999.
293. Wille H, Drewes G, Biernat J, Mandelkow EM, and Mandelkow E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J Cell Biol 118: 573-584, 1992.
294. Williamson R, Scales T, Clark BR, Gibb G, Reynolds CH, Kellie S, Bird IN, Varndell IM, Sheppard PW, Everall I, and Anderton BH. Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases. J Neurosci 22: 10-20, 2002.
295. Wilson DM and Binder LI. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol 150: 2181-2195, 1997.
296. Wischik CM, Crowther RA, Stewart M, and Roth M. Subunit structure of paired helical filaments in Alzheimer's disease. J Cell Biol 100: 1905-1912, 1985.
297. Wischik CM, Lai RYK, and Harrington CR. Modelling prion-like processing of tau protein in Alzheimer's disease for pharmaceutical development. In: Brain Microtubule Associated, edited by Avila J, Brandt R, and Kosik KS. Chur, Switzerland: Harwood Academic, 1997, p. 185-241.
298. Wisniewski HM, Narang HK, and Terry RD. Neurofibrillary tangles of paired helical filaments. J Neurol Sci 27: 173-181, 1976.
299. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, and Feany MB. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293: 711-714, 2001.
300. Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, and Martins R. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 22: RC221, 2002.
301. Yamamoto A, Lucas JJ, and Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101: 57-66, 2000.
302. Yamamoto H, Hasegawa M, Ono T, Tashima K, Ihara Y, and Miyamoto E. Dephosphorylation of fetal-tau and paired helical filaments-tau by protein phosphatases 1 and 2A and calcineurin. J Biochem 118: 1224-1231, 1995.
303. Yan SD, Chen X, Schmidt AM, Brett J, Godman G, Zou YS, Scott CW, Caputo C, Frappier T, Smith MA, Perry G, Yen SH, and Stem D. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 91: 7787-7791, 1994.
304. Yankner BA. New clues to Alzheimer's disease: unraveling the roles of amyloid and tau. Nature Med 2: 850-852, 1996.
305. Yin HS, Chou HC, and Chiu MM. Changes in the microtubule proteins in the developing and transected spinal cords of the bullfrog tadpole: induction of microtubule-associated protein 2c and enhanced levels of Tau and tubulin in regenerating central axons. Neuroscience 67: 763-775, 1995.
306. Yoo BC and Lubec G. p25 protein in neurodegeneration. Nature 411: 763-765, 2001.
307. Yoshida H and Goedert M. Molecular cloning and functional characterization of chicken brain tau: isoforms with up to five tandem repeats. Biochemistry 41: 15203-15211, 2002.
308. Zhou ZX, Kops O, Werner A, Lu JP, Shen M, Stoller G, Kullertz G, Stark M, Fischer G, and Lu PK. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell 6: 873-883, 2000.